Press "Enter" to skip to content

Bon Secours Mercy Health Partners With Lirio AI Platform

Bon Secours Mercy Health has signed an accord with Tennessee-based behavior change startup Lirio, initiating a direct investment to develop its artificial intelligence platform further.

Along with the strategic investment, Bon Secours Mercy Health CEO John Starcher will be part of Lirio’s managerial board, in response to the Cincinnati-based health system, which has over 1,000 care sites throughout seven U.S. states and in Eire.

Together, the two organizations will “co-develop new behavior change packages that target at-risk populations proactively and preventatively in ways in which both enhance care quality and obtain operational efficiencies,” Mike West, Lirio’s chairman, and CEO said.

These programs can be geared toward altering healthcare habits for those sufferers at risk for continual ailments such as diabetes and hypertension.

The ultimate objective is to market commercially to other health programs worldwide.

In the shorter span, Bon Secours Mercy Wellbeing will license Lirio’s present behavior change programs, akin to patient engagement technologies aimed toward women’s health.

Clinicians, there will also achieve access to Lirio’s behavioral scientists, data scientists, and AI researchers, enabling new improvements for population health analytics and group partnerships to deal with social determinants of health.

Bon Secours Mercy Health, the fifth-largest Catholic health system and one of the 20 largest techniques in the U.S., has a reputation for patient safety, and as an early follower of health IT.

Lirio’s efforts on patient engagement and behavior change front are increasing.

Along with the new collaboration with Bon Secours Mercy, the firm further declared this month that it has opened a new research laboratory, the Behavioral Reinforcement Learning Lab (BReLL), and hired John Seely Brown, a longtime researcher into the human impact of digital applied sciences, as a scientific consultant.

Be First to Comment

Leave a Reply

Your email address will not be published. Required fields are marked *